SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 116 filers reported holding SYNAGEVA BIOPHARMA CORP in Q1 2014. The put-call ratio across all filers is 2.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $19,660,000 | +3.2% | 201,582 | -1.8% | 0.01% | 0.0% |
| Q4 2014 | $19,046,000 | +45.3% | 205,265 | +7.7% | 0.01% | +42.9% |
| Q3 2014 | $13,108,000 | -72.5% | 190,589 | -58.1% | 0.01% | -46.2% |
| Q2 2014 | $47,622,000 | +152.6% | 454,402 | +100.0% | 0.01% | +18.2% |
| Q1 2014 | $18,851,000 | +51.5% | 227,201 | +18.2% | 0.01% | +57.1% |
| Q4 2013 | $12,439,000 | +2.2% | 192,201 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $12,168,000 | +176.2% | 192,201 | +83.3% | 0.01% | +133.3% |
| Q2 2013 | $4,405,000 | – | 104,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|